{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:41:03Z","timestamp":1771054863090,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:sec>\n                    <jats:title>What's known on the subject? and What does the study add?<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            With an aging population and routine use of\n                            <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                            testing, there is an increase in men undergoing biopsy to assess for prostate cancer. The most common route for accessing the prostate is through the rectum, which potentially exposes the patient to otherwise innocuous\n                            <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>\n                            nterobacteriaceae. The rising incidence of extended\u2010spectrum beta\u2010lactamase has been linked to a rise in post\u2010\n                            <jats:styled-content style=\"fixed-case\">TRUS<\/jats:styled-content>\n                            biopsy infection rates internationally.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The study describes an alternative route for biopsy of the prostate that is associated with a very low infection rate, whilst still maintaining a good tumour detection rate.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To present the template\u2010guided transperineal prostate biopsy (\n                            <jats:styled-content style=\"fixed-case\">TPB<\/jats:styled-content>\n                            ) outcomes for patients of two urologists from a single institution.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            We conducted a prospective study of 409 consecutive men who underwent\n                            <jats:styled-content style=\"fixed-case\">TPB<\/jats:styled-content>\n                            between\n                            <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                            ecember 2006 and\n                            <jats:styled-content style=\"fixed-case\">J<\/jats:styled-content>\n                            une 2008 in a tertiary referral centre using a standardized 14\u2010region technique.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The procedure was performed as day surgery under general anaesthesia with fluoroquinolone antibiotic cover.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Follow\u2010up took place within 2 weeks, during which time men were interviewed using a standardized template.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Results were compared with those of the\n                            <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                            ustralian national prostate biopsy audits performed by the\n                            <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>\n                            rological\n                            <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                            ociety of\n                            <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                            ustralia and\n                            <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>\n                            ew\n                            <jats:styled-content style=\"fixed-case\">Z<\/jats:styled-content>\n                            ealand (\n                            <jats:styled-content style=\"fixed-case\">USANZ<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Indications for biopsy included elevated prostate\u2010specific antigen (\n                            <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                            ) level (75%), with a median\n                            <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                            level of 6.5\u2009ng\/\n                            <jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>\n                            , abnormal digital rectal examination (8%) and active surveillance (\n                            <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n                            ) re\u2010staging (18%).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The mean patient age was 63 years and two\u2010thirds of patients were undergoing their first biopsy.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            A positive biopsy was found in 232 men, 74% of whom had a\n                            <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>\n                            leason score of \u22657. The overall cancer detection rate was 56.7% (\n                            <jats:styled-content style=\"fixed-case\">USANZ<\/jats:styled-content>\n                            2005 national audit = 56.5%). Stratified between those having their first\n                            <jats:styled-content style=\"fixed-case\">TPB<\/jats:styled-content>\n                            or a repeat procedure (after a previous negative biopsy), the detection rates were 64.4 and 35.6%, respectively. Significantly higher detection rates were found in prostates &lt;50\u2009mL in volume than in larger prostates (65.2 vs 38.3%, respectively,\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Haematuria was the most common side effect (51.7%). Others included dysuria (16.4%), acute urinary retention (4.2%) and fever (3.2%). One patient (0.2%) had septicaemia requiring i.v. antibiotics.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Repeat biopsy was not associated with increased complication rates.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:styled-content style=\"fixed-case\">TPB<\/jats:styled-content>\n                            is a safe and efficacious technique, with a cancer detection rate of 56.7% in the present series, and a low incidence of major side effects. Stratified by prostate volume, the detection rate of\n                            <jats:styled-content style=\"fixed-case\">TPB<\/jats:styled-content>\n                            was higher in smaller glands.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Given the relatively low rate of serious complications, clinicians could consider increasing the number of\n                            <jats:styled-content style=\"fixed-case\">TPB<\/jats:styled-content>\n                            biopsy cores in larger prostates as a strategy to improve cancer detection within this group. Conversely, in patients on\n                            <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>\n                            programmes, a staging\n                            <jats:styled-content style=\"fixed-case\">TPB<\/jats:styled-content>\n                            may be a superior approach for patients undergoing repeat biopsy so as to minimize their risk of serious infection.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11657.x","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T08:21:12Z","timestamp":1364977272000},"page":"585-593","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Outcomes of transperineal template\u2010guided prostate biopsy in 409 patients"],"prefix":"10.1111","volume":"112","author":[{"given":"James L.","family":"Symons","sequence":"first","affiliation":[{"name":"Cancer Research Programme Garvan Institute of Medical Research  Darlinghurst NSW Australia"},{"name":"St Vincent's Prostate Cancer Centre  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Huo","sequence":"additional","affiliation":[{"name":"Cancer Research Programme Garvan Institute of Medical Research  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo L.","family":"Yuen","sequence":"additional","affiliation":[{"name":"Department of Urology St. Vincent's Hospital  Darlinghurst NSW Australia"},{"name":"Department of Urology St. Vincent's Clinic  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne\u2010Maree","family":"Haynes","sequence":"additional","affiliation":[{"name":"Cancer Research Programme Garvan Institute of Medical Research  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne","family":"Matthews","sequence":"additional","affiliation":[{"name":"St Vincent's Prostate Cancer Centre  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Cancer Research Programme Garvan Institute of Medical Research  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Brenner","sequence":"additional","affiliation":[{"name":"Department of Urology St. Vincent's Hospital  Darlinghurst NSW Australia"},{"name":"Department of Urology St. Vincent's Clinic  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip D.","family":"Stricker","sequence":"additional","affiliation":[{"name":"St Vincent's Prostate Cancer Centre  Darlinghurst NSW Australia"},{"name":"Department of Urology St. Vincent's Hospital  Darlinghurst NSW Australia"},{"name":"Department of Urology St. Vincent's Clinic  Darlinghurst NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)38664-0"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65322-9"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67995-5"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)63574-2"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67993-1"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-006-0592-3"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00313-6"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eeus.2007.08.001"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0004-8461.2003.01143.x"},{"key":"e_1_2_8_11_1","volume-title":"Prostate Biopsy Audit Report","author":"USANZ","year":"2005"},{"key":"e_1_2_8_12_1","volume-title":"Prostate Biopsy Audit Report","author":"USANZ","year":"2007"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000099824.73886.f3"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00681-6"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21020"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2004.00863.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10298"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.01.051"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00574-3"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01958-1"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000116449.01186.f7"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01810.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-8-14"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000132134.10470.75"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2009.42"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.11.019"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.10.071"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2010.51.6.426"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.2180"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01975.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.12.078"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10528.x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.4.657-686.2005"},{"key":"e_1_2_8_35_1","first-page":"3653","article-title":"Extended\u2010spectrum beta\u2010lactamase gram\u2010negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis","volume":"14","author":"Cannon GM","year":"2007","journal-title":"Can J Urol"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.09.057"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.02.041"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(02)00055-6"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000082703"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.08.008"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.01.017"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/00313020310001619154"},{"key":"e_1_2_8_43_1","volume-title":"Anatomy of the Prostate: Implication for Disease","author":"McNeal JE","year":"1990"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02551-7"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-005-0547-0"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2005.01186.x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.06.1126"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11657.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11657.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:06:40Z","timestamp":1761761200000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11657.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11657.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11657.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]},"assertion":[{"value":"2013-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}